// CODE SNIPPET
1910.1027(l)(2)(ii)(B) Biological Monitoring That Includes the Following Tests:
JUMP TO FULL CODE CHAPTER
Cadmium in urine (CdU), standardized to grams of creatinine (g/Cr);
Beta-2 microglobulin in urine (B(2)-M), standardized to grams of creatinine (g/Cr), with pH specified, as described in Appendix F; and
Cadmium in blood (CdB), standardized to liters of whole blood (lwb).
Related Code Sections
1910.1027(l)(2)(ii)(B) Toxic and Hazardous Substances, Biological Monitoring That Includes the Following Tests:
Cadmium in urine (CdU), standardized to grams of creatinine (g/Cr ...
OSHA 1910 General Industry > Z Toxic and Hazardous Substances > 1910.1027 Cadmium > 1910.1027(l) Medical Surveillance > 1910.1027(l)(2) Initial Examination > 1910.1027(l)(2)(ii) The Initial (Preplacement) Medical Examination Shall Include: > 1910.1027(l)(2)(ii)(B) Biological Monitoring That Includes the Following Tests:
1910.1025(j)(2) Toxic and Hazardous Substances, Biological Monitoring -
Blood lead and ZPP level sampling and analysis. The employer shall make available biological monitoring in the form of blood sampling and analysis ...
OSHA 1910 General Industry > Z Toxic and Hazardous Substances > 1910.1025 Lead > 1910.1025(j) Medical Surveillance - > 1910.1025(j)(2) Biological Monitoring -
1910.1027(l)(4) Toxic and Hazardous Substances, Periodic Medical Surveillance
300 µg/g Cr in the initial biological monitoring tests, and if the results of the followup biological monitoring required byparagraph (l)(3)(i)(B ...
OSHA 1910 General Industry > Z Toxic and Hazardous Substances > 1910.1027 Cadmium > 1910.1027(l) Medical Surveillance > 1910.1027(l)(4) Periodic Medical Surveillance
1910.1027(l)(4)(v) Toxic and Hazardous Substances, For Previously Exposed Employees Under Paragraph (L)(1)(I)(B):
biological monitoring tests, and if the results of the followup biological monitoring required byparagraph (l)(3)(i)(B) of this section one year after ...
OSHA 1910 General Industry > Z Toxic and Hazardous Substances > 1910.1027 Cadmium > 1910.1027(l) Medical Surveillance > 1910.1027(l)(4) Periodic Medical Surveillance > 1910.1027(l)(4)(v) For Previously Exposed Employees Under Paragraph (L)(1)(I)(B):
1910.1025(j)(2)(ii) Toxic and Hazardous Substances,
Follow-up blood sampling tests. Whenever the results of a blood lead level test indicate that an employee's blood lead level is at or above ...
OSHA 1910 General Industry > Z Toxic and Hazardous Substances > 1910.1025 Lead > 1910.1025(j) Medical Surveillance - > 1910.1025(j)(2) Biological Monitoring - > 1910.1025(j)(2)(ii)